ACADIA Pharmaceuticals Inc (ACAD)
Debt-to-equity ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 732,793 | 577,180 | 516,700 | 464,044 | 431,755 | 362,174 | 395,793 | 374,258 | 400,413 | 425,686 | 434,848 | 444,797 | 540,894 | 566,955 | 564,838 | 581,606 | 627,009 | 654,867 | 663,013 | 638,382 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $732,793K
= 0.00
The debt-to-equity ratio for ACADIA Pharmaceuticals Inc has consistently been 0.00 across various quarters from March 31, 2020, to December 31, 2024. This indicates that the company has not utilized any debt to finance its operations during this period and has relied solely on equity financing. A debt-to-equity ratio of 0.00 signifies that the company has no debt obligations relative to its equity, which can be viewed positively by investors and creditors as it suggests a lower financial risk and a strong financial position. ACADIA Pharmaceuticals' consistent low debt-to-equity ratio may indicate a conservative financial strategy focused on maintaining a healthy balance sheet and financial stability.
Peer comparison
Dec 31, 2024